WSJ News Exclusive | FDA Delays Moderna Covid-19 Vaccine for Adolescents to Review Rare Myocarditis Side Effect
The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -2.41% Covid-19 vaccine for adolescents to...
The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -2.41% Covid-19 vaccine for adolescents to...
Johnson & Johnson said Wednesday that a second dose of its Covid-19 vaccine was found in a study to generate...
The Biden administration took steps Wednesday to crack down on rising Covid-19 cases, including a call for a third shot...
The U.S. has purchased 200 million additional Covid-19 vaccine doses from Pfizer Inc. PFE 0.51% and partner BioNTech SE, BNTX...
TAIPEI—Taiwan is struggling with the pandemic, short on vaccines and locked in a geopolitical fight with China over access to...
Pfizer Inc. will seek clearance from U.S. regulators in coming weeks to distribute a booster shot of its Covid-19 vaccine...